William Blair & Company
PHAS

William Blair & Company’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

William Blair & Company’s Portfolio PHAS Stock Details PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$6K Hold
2022
Q2 		$21K Hold
2022
Q1 		$47K Buy
2021
Q4 		$60K Buy
2021
Q3 		$56K Buy
2021
Q2 		$63K Sell
2021
Q1 		$368K Buy
2020
Q4 		$227K Buy